Insider Transactions in Q3 2023 at Centessa Pharmaceuticals PLC (CNTA)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2023
|
Iqbal J Hussain General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
7,520
-3.75%
|
$45,120
$6.47 P/Share
|
|
Sep 30
2023
|
Gregory M Weinhoff Chief Business Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
11,742
-4.18%
|
$70,452
$6.47 P/Share
|
|
Sep 30
2023
|
David J Grainger Chief Innovation Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,700
-0.48%
|
$28,200
$6.47 P/Share
|
|
Sep 30
2023
|
David M Chao Chief Administrative Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,419
-3.77%
|
$62,514
$6.47 P/Share
|
|
Sep 30
2023
|
Saurabh Saha Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
36,263
-4.22%
|
$217,578
$6.47 P/Share
|
|
Sep 30
2023
|
Tia L Bush Chief Technology & Quality Ofc |
SELL
Payment of exercise price or tax liability
|
Direct |
6,419
-4.26%
|
$38,514
$6.47 P/Share
|
|
Sep 20
2023
|
Harris Rotman SVP Regulatory Affairs |
SELL
Open market or private sale
|
Direct |
37,484
-52.81%
|
$224,904
$6.29 P/Share
|
|
Sep 20
2023
|
Harris Rotman SVP Regulatory Affairs |
BUY
Exercise of conversion of derivative security
|
Direct |
37,484
+20.31%
|
$149,936
$4.16 P/Share
|